Zydus Lifesciences: Robust outlook for both US and India biz
Recommendation: Add; Target price: ₹885
Source: indiainfoline.com
Page 32 - Options Segment News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Options Segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Options Segment Today - Breaking & Trending Today
Jyothy Laboratories: Hopeful of a Rural Recovery
Recommendation: Buy; Target price: ₹550
Source: indiainfoline.com
Star Health: Not in the superficial race for topline growth
Recommendation: Buy; Target price: ₹700
Source: indiainfoline.com
Paytm Shares Dip 5% as Circuit Limit Revised Amid Regulatory Scrutiny
This revision came a day after Paytm shares were locked at their 10% lower circuit limit
Source: indiainfoline.com
CG Power & Industrial: Sustainable growth path
Recommendation: Buy; Target price: ₹519
Source: indiainfoline.com